GlaxoSmithKline

Aktienkurs
2,213.00
Täglich Wechseln
-13.00 -0.58%
Monatlich
22.64%
Jährlich
52.36%
Q1 Prognose
2,168.74




Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Alcon AG USD 654M 404M 2025-09
Amgen USD 5.14B 775M 2025-12
argenx SE USD 288.02M 84.53M 2025-06
AstraZeneca USD 5.23B 272M 2025-09
Bayer EUR 1.51B 1.28B 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 931.26M 60.26M 2025-09
Galapagos EUR -158.71M 177.84M 2025-03
Genmab DKK 477M 101M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.46B 45M 2025-06
Merck USD 8.39B 1.97B 2025-09
Novartis USD 5.88B 290M 2025-09
Novo Nordisk DKK 37.3B 5.86B 2025-12
Orion EUR 343M 207.9M 2025-12
Pfizer USD 6.08B 351M 2025-09
Philips EUR 738M 9M 2025-09
Recordati EUR 247.57M 21.38M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Smith & Nephew USD 796M 139M 2025-12
UCB EUR 1.03B 334M 2025-06


GlaxoSmithKline - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.